{"id":48108,"date":"2022-09-08T14:02:33","date_gmt":"2022-09-08T12:02:33","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/"},"modified":"2022-09-08T14:02:33","modified_gmt":"2022-09-08T12:02:33","slug":"llr-partners-announces-significant-growth-investment-in-vpl","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/","title":{"rendered":"LLR Partners Announces Significant Growth Investment in VPL"},"content":{"rendered":"
\n

PHILADELPHIA & WESTERVILLE, Ohio–(BUSINESS WIRE)–#LLR<\/a>—LLR Partners<\/a> today announced a significant growth investment in Vantage Point Logistics<\/a> (\u201cVPL\u201d), a supply chain management software provider that helps healthcare organizations improve resiliency and visibility of clinical supply chains. The capital will be used to support VPL\u2019s continued product innovation and organic growth along with the exploration of strategic acquisitions. VPL\u2019s current institutional investors, Radian Capital and Tamarind Hill, remain minority shareholders in the business.\n<\/p>\n

<\/a><\/p>\n

\n\u201cVPL has developed an innovative platform of supply chain solutions for health systems, specialty pharmacies, and surgery centers bringing efficiency and cost savings to these organizations,\u201d said Zack Sigal, Partner at LLR. \u201cProvider consolidation, shifts in site of care, and heightened focus on expense management have caused healthcare organizations to increasingly adopt technology solutions to drive clinical efficiency and savings. We\u2019re excited to partner with VPL as they support more healthcare organizations to deliver more efficient care.\u201d\n<\/p>\n

\nVPL\u2019s platform enables coordination and collaboration between healthcare suppliers, providers, and patients through its inbound freight (Surpass), outbound shipping (Traject and TrajectRx), track and trace visibility (View) and enhanced analytics (Percept) solutions. Today, the platform manages more than 6,000 suppliers across all facets of healthcare, including IDNs, critical access, outpatient, and pharmacy.\n<\/p>\n

\n\u201cVPL is trusted by more than 700 hospitals to deliver savings, insights, and peace of mind,\u201d said Eric McGlade, Co-Founder and CEO of VPL. \u201cLLR\u2019s experience partnering with healthcare and technology businesses to support their growth will be exceptionally valuable as we continue to deliver benefits from reduced costs, better insights, and increased transparency and efficiency to healthcare organizations.\u201d\n<\/p>\n

\n\u201cIt has been exciting to work with VPL and support their significant growth over the past several years,\u201d said Aly Lovett from Radian Capital. \u201cWe look forward to continuing our partnership alongside LLR and supporting VPL\u2019s next stage of growth.\u201d\n<\/p>\n

\nPiper Sandler served as exclusive financial advisor to VPL in this transaction.\n<\/p>\n

\nAbout LLR Partners<\/b>\n<\/p>\n

\nLLR Partners is a private equity firm investing in technology and healthcare businesses. We collaborate with our portfolio companies to identify and execute on key growth initiatives and help create long-term value. Founded in 1999 and with more than $5 billion raised across six funds, LLR is a flexible provider of equity capital for growth, recapitalizations and buyouts. Learn more at https:\/\/www.llrpartners.com\/<\/a>.\n<\/p>\n

\nAbout VPL<\/b>\n<\/p>\n

\nVPL is a software company delivering visibility and resiliency to clinical supply chains. By making the procurement-through-fulfillment processes smarter and more profitable, it creates a new supplier dynamic whereby customers benefit from reduced costs, better insights, and increased transparency and efficiency. VPL developed the industry\u2019s only Smart Supply Chain Platform, which automates inbound and outbound shipping, unlocks visibility into the status of critical shipments, and identifies cost-savings opportunities for all of healthcare. For more information, visit www.getvpl.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nKristy DelMuto
\n
LLR Partners
\n
215-344-1372
\n
kdelmuto@llrpartners.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

PHILADELPHIA & WESTERVILLE, Ohio–(BUSINESS WIRE)–#LLR—LLR Partners today announced a significant growth investment in Vantage Point Logistics (\u201cVPL\u201d), a supply chain management software provider that helps healthcare organizations improve resiliency and visibility of clinical supply chains. The capital will be used to support VPL\u2019s continued product innovation and organic growth along with the exploration of strategic … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48108","6":"format-standard","7":"category-industry"},"yoast_head":"\nLLR Partners Announces Significant Growth Investment in VPL - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LLR Partners Announces Significant Growth Investment in VPL - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA & WESTERVILLE, Ohio–(BUSINESS WIRE)–#LLR—LLR Partners today announced a significant growth investment in Vantage Point Logistics (\u201cVPL\u201d), a supply chain management software provider that helps healthcare organizations improve resiliency and visibility of clinical supply chains. The capital will be used to support VPL\u2019s continued product innovation and organic growth along with the exploration of strategic ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-08T12:02:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220908005070\/en\/1565320\/21\/VPL_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/llr-partners-announces-significant-growth-investment-in-vpl\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/llr-partners-announces-significant-growth-investment-in-vpl\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"LLR Partners Announces Significant Growth Investment in VPL\",\"datePublished\":\"2022-09-08T12:02:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/llr-partners-announces-significant-growth-investment-in-vpl\\\/\"},\"wordCount\":484,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/llr-partners-announces-significant-growth-investment-in-vpl\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005070\\\/en\\\/1565320\\\/21\\\/VPL_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/llr-partners-announces-significant-growth-investment-in-vpl\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/llr-partners-announces-significant-growth-investment-in-vpl\\\/\",\"name\":\"LLR Partners Announces Significant Growth Investment in VPL - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/llr-partners-announces-significant-growth-investment-in-vpl\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/llr-partners-announces-significant-growth-investment-in-vpl\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005070\\\/en\\\/1565320\\\/21\\\/VPL_Logo.jpg\",\"datePublished\":\"2022-09-08T12:02:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/llr-partners-announces-significant-growth-investment-in-vpl\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/llr-partners-announces-significant-growth-investment-in-vpl\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/llr-partners-announces-significant-growth-investment-in-vpl\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005070\\\/en\\\/1565320\\\/21\\\/VPL_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005070\\\/en\\\/1565320\\\/21\\\/VPL_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/llr-partners-announces-significant-growth-investment-in-vpl\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LLR Partners Announces Significant Growth Investment in VPL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LLR Partners Announces Significant Growth Investment in VPL - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/","og_locale":"en_US","og_type":"article","og_title":"LLR Partners Announces Significant Growth Investment in VPL - Pharma Trend","og_description":"PHILADELPHIA & WESTERVILLE, Ohio–(BUSINESS WIRE)–#LLR—LLR Partners today announced a significant growth investment in Vantage Point Logistics (\u201cVPL\u201d), a supply chain management software provider that helps healthcare organizations improve resiliency and visibility of clinical supply chains. The capital will be used to support VPL\u2019s continued product innovation and organic growth along with the exploration of strategic ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-08T12:02:33+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220908005070\/en\/1565320\/21\/VPL_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"LLR Partners Announces Significant Growth Investment in VPL","datePublished":"2022-09-08T12:02:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/"},"wordCount":484,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220908005070\/en\/1565320\/21\/VPL_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/","url":"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/","name":"LLR Partners Announces Significant Growth Investment in VPL - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220908005070\/en\/1565320\/21\/VPL_Logo.jpg","datePublished":"2022-09-08T12:02:33+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220908005070\/en\/1565320\/21\/VPL_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220908005070\/en\/1565320\/21\/VPL_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/llr-partners-announces-significant-growth-investment-in-vpl\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"LLR Partners Announces Significant Growth Investment in VPL"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48108"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48108\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}